原发性硬化性胆管炎
蛋白质组
胆道
免疫染色
生物标志物
胆管
蛋白质组学
生物标志物发现
生物
医学
病理
胃肠病学
内科学
免疫组织化学
生物化学
疾病
基因
作者
Motoyasu Kan,Tetsuhiro Chiba,Ryo Konno,Yusuke Kouchi,Takashi Mishima,Yusuke Kawashima,Takashi Kishimoto,Masayuki Ohtsuka,Osamu Ohara,Naoya Kato
摘要
BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of unknown etiology that affects the intra- and extrahepatic bile ducts. The present study examined the utility of a bile proteome analysis using a high-sensitivity mass spectrometer to comprehensively screen for novel PSC biomarkers. METHODS: Bile endoscopically collected from patients with PSC, common bile duct stones, and biliary tract cancer were subjected to high-precision liquid chromatography/mass spectrometry. Some of the proteins specifically up-regulated in the bile of the PSC group were re-examined by an enzyme-linked immunosorbent assay. RESULTS: A total of 8094 proteins were successfully identified and 332 were specifically up-regulated in the PSC group. The bioinformatics analysis showed that proteins involved in the proliferation and activation of diverse inflammatory cells were up-regulated in the PSC group. A receiver operating characteristic curve analysis showed good area under the curve values for interleukin-8 and annexin A1 (ANXA1) (0.836 and 0.914, respectively). Immunostaining for ANXA1 revealed its strong expression in inflammatory cells infiltrating the peripheral biliary tract in PSC livers. CONCLUSION: A bile proteome analysis is a useful tool for elucidating the pathogenesis of PSC and developing new diagnostic approaches. Therefore, ANXA1 has potential as a bile biomarker for PSC.
科研通智能强力驱动
Strongly Powered by AbleSci AI